Do Negative (124)I Pretherapy Positron Emission Tomography Scans in Patients with Elevated Serum Thyroglobulin Levels Predict Negative (131)I Posttherapy Scans?

Background: The management of patients with differentiated thyroid cancer (DTC) who have elevated serum thyroglobulin (Tg) levels and negative (131)I or (123)I scans is problematic, and the decision regarding whether or not to administer (131)I therapy (a “blind” therapy) is also problematic. While...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khorjekar, Gauri R., Van Nostrand, Douglas, Garcia, Carlos, O'Neil, Jeffrey, Moreau, Shari, Atkins, Francis B., Mete, Mihriye, Orquiza, Michael H., Burman, Kenneth, Wartofsky, Leonard
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2014
Assuntos:
Thyroid Radiology and Nuclear Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4148053/
https://ncbi.nlm.nih.gov/pubmed/24820222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2013.0713
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados